Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats: Part 1
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Submicrometer TiO2 particles, including nanoparticulate fractions, are used in an increasing variety of consumer products, as food additives and also drug delivery applications are envisaged. Beyond exposure of occupational groups, this entails an exposure risk to the public. However, nanoparticle translocation from the organ of intake and potential accumulation in secondary organs are poorly understood and in many investigations excessive doses are applied. The present study investigates the biokinetics and clearance of a low single dose (typically 40–400 μg/kg BW) of 48V-radiolabeled, pure TiO2 anatase nanoparticles ([48V]TiO2NP) with a median aggregate/agglomerate size of 70 nm in aqueous suspension after intravenous (IV) injection into female Wistar rats. Biokinetics and clearance were followed from one-hour to 4-weeks. The use of radiolabeled nanoparticles allowed a quantitative [48V]TiO2NP balancing of all organs, tissues, carcass and excretions of each rat without having to account for chemical background levels possibly caused by dietary or environmental titanium exposure. Highest [48V]TiO2NP accumulations were found in liver (95.5%ID after one day), followed by spleen (2.5%), carcass (1%), skeleton (0.7%) and blood (0.4%). Detectable nanoparticle levels were found in all other organs. The [48V]TiO2NP content in blood decreased rapidly after 24 h while the distribution in other organs and tissues remained rather constant until day-28. The present biokinetics study is part 1 of a series of studies comparing biokinetics after three classical routes of intake (IV injection (part 1), ingestion (part 2), intratracheal instillation (part 3)) under identical laboratory conditions, in order to test the common hypothesis that IV-injection is a suitable predictor for the biokinetics fate of nanoparticles administered by different routes. This hypothesis is disproved by this series of studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb07033.x · Cited by 920 · cited 1×
“Also for absorbed TiO2NP across the human gut, no consolidated data are available but based on animal data the daily absorbed TiO2NP fraction should be 5% or less (Jani et al., 1990).”
BackgroundNano-TiO2– feasibility and challenges for human health risk assessment based on open literature
Christensen, F. M., Johnston, H. J., Stone, V., Aitken, R. J., Hankin, S., Peters, S., & Aschberger, K. (2011) · Nanotoxicology · doi:10.3109/17435390.2010.504899 · Cited by 141
Hazard Assessments of Manufactured Nanomaterials
Morimoto, Y., Kobayashi, N., Shinohara, N., Myojo, T., Tanaka, I., & Nakanishi, J. (2010) · Journal of Occupational Health · doi:10.1539/joh.r10003 · Cited by 83
Cited by
Biodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials
Bourquin, J., Milosevic, A., Hauser, D., Lehner, R., Blank, F., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2018) · Advanced Materials · doi:10.1002/adma.201704307 · Cited by 461
Safety assessment of titanium dioxide (E171) as a food additive
(FAF), E. P. O. F. A. A. F., Younes, M., Aquilina, G., Castle, L., Engel, K., Fowler, P., Frutos Fernandez, M. J., Fürst, P., Gundert‐Remy, U., Gürtler, R., et al. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6585 · Cited by 314
Hesler, M., Aengenheister, L., Ellinger, B., Drexel, R., Straskraba, S., Jost, C., Wagner, S., Meier, F., von Briesen, H., Büchel, C., et al. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.104610 · Cited by 291
“Studies with polymeric particles applied as drug delivery systems showed cellular uptake of the particles in the human in vitro models Caco-2 and MDCK (Kulkarni and Feng, 2013) as well as the biodistribution in vivo (Hussain et al., 2001; Schmidt et al., 2013).”
MethodParticle toxicology and health - where are we?
Riediker, M., Zink, D., Kreyling, W., Oberdörster, G., Elder, A., Graham, U., Lynch, I., Duschl, A., Ichihara, G., Ichihara, S., et al. (2019) · Particle and Fibre Toxicology · doi:10.1186/s12989-019-0302-8 · Cited by 237
Self-citationIn vivo effects: Methodologies and biokinetics of inhaled nanomaterials
Oberdörster, G., & Kuhlbusch, T. A. J. (2018) · NanoImpact · doi:10.1016/j.impact.2017.10.007 · Cited by 88
Metadata
- Authors
- Kreyling, W. G., Holzwarth, U., Haberl, N., Kozempel, J., Hirn, S., Wenk, A., Schleh, C., Schäffler, M., Lipka, J., Semmler-Behnke, M., & Gibson, N.
- Venue
- Nanotoxicology
- Publisher
- Informa UK Limited
- Published
- 2017-04-03
- Volume
- 11
- Issue
- 4
- Pages
- 434-442
- ISSN
- 1743-5390 (ISSN-L)
- 1743-5404
- OpenAlex
- W2604946521
- Cited by
- 88
- References
- 3
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats: Part 1. https://app.cochat.ai/papers/10.1080/17435390.2017.1306892
- The paper
- Kreyling, W. G., Holzwarth, U., Haberl, N., Kozempel, J., Hirn, S., Wenk, A., Schleh, C., Schäffler, M., Lipka, J., Semmler-Behnke, M., & Gibson, N. (2017). Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats: Part 1. Nanotoxicology. https://doi.org/10.1080/17435390.2017.1306892
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.